Evan Yu, MD
Enriched profileProfessor, Division of Hematology and Oncology, University of Washington School of Medicine; Section Head, Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Center · University of Washington School of Medicine
Evan Yu is Professor, Division of Hematology and Oncology, University of Washington School of Medicine; Section Head, Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Center at University of Washington School of Medicine. OpenAlex indexes 118 publications with 5,760 citations (h-index 22); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 15 Oct 2026
Evan Ya-Wen Yu is Professor, Division of Hematology and Oncology, University of Washington School of Medicine. The public record shows 118 publications with 5,760 citations (h-index 22), centered on Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Nutritional Studies and Diet. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 18 companies, 3 NIH-funded awards (2007–2026).
- Most recent indexed publication: 2026 · Cell discovery
- Top research focus: Bladder and Urothelial Cancer Treatments
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 38.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Sponsor: University of Washington
- Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma
Sponsor: University of Washington
Industry payments
Updated 15 Oct 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year202523 payments$23,920openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202520 payments$13,252openpaymentsdata.cms.gov ↗
- Astellas Pharma Global DevelopmentProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
62.8%Cytochrome P450 17A1 Inhibitor34.9%Abiraterone Acetate100%Part D<11 patientsAnti-androgens15.1%Nubeqa100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
37.2%Corticosteroid37.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
3 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Hutchinson Center as Lead Academic Participating Site (UG1)
Fred Hutchinson Cancer Center
FY2026$657,177UG1CA233328
Congress activity
Updated 15 Oct 2026
16 congress contributions (2013–2025) across AACR, ASCO, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Trans-ethnic estimation and implications of genetic impact on continuous glycemic profiles.
Cell discovery
Article2026 - Correction to "Proteomic Profiling of Urinary Large Extracellular Vesicles for the Diagnosis of Prostate Cancer".
Analytical chemistry
Erratum2025 - Proteomic Profiling of Urinary Large Extracellular Vesicles for the Diagnosis of Prostate Cancer.
Analytical chemistry
Article2025
Most-cited works
by citation count (OpenAlex)- 01Lentivirus-delivered stable gene silencing by RNAi in primary cellsArticle1,664 citations2003
- 02Quantitative and stoichiometric analysis of the microRNA content of exosomesArticle1,105 citations2014
- 03Telomerase maintains telomere structure in normal human cellsArticle735 citations2006
- 04Integrative Clinical Genomics of Advanced Prostate CancerArticle591 citations2015
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/evan-yu-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
urotoday.com/video-lectures/psma-and-beyond-2026-conference-videos/video/5530-modalities-for-targeting-the-cell-surface-presentation-evan-yu.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urotoday.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
- M.D.
University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - B.S.
Zoology, University of Washington
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗ - Residency
Internal Medicine, Brigham and Women's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Fellowship
Hematology-Oncology, Dana-Farber Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Editorial & leadership roles
journal and society appointments- Senior Editor
Clinical Cancer Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Senior Editor
UroToday
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Co-chair
National Cancer Institute Prostate Cancer Task Force
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Member
National Cancer Institute Genitourinary Cancers Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Secondary affiliations
appointments beyond the home institution- Fred Hutchinson Cancer Center - Section Head
Medical Oncology, Clinical Research Division
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)